We tested 59 common and 27 uncommon Aspergillus species isolates for the susceptibility to the mold-active azole antifungal agents, itraconazole, voriconazole, and posaconazole, using the Sensititre method. The overall essential agreement with the CLSI reference method was 96.5% for itraconazole and posaconazole, and 100% for voriconazole. By Sensititre, as well as CLSI, all of 10 A. fumigatus isolates with a cyp51 mutant genotype were classified as being non-wild-type (MIC > ECV) to triazoles.

Mello, E., Posteraro, B., Vella, A., De Carolis, E., Torelli, R., D'Inzeo, T., Verweij, P. E., Sanguinetti, M., Susceptibility Testing of Common and Uncommon Aspergillus Species Against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method, <<ANTIMICROBIAL AGENTS AND CHEMOTHERAPY>>, 2017; 61 (6): 00168-17-N/A. [doi:10.1128/AAC.00168-17] [http://hdl.handle.net/10807/98185]

Susceptibility Testing of Common and Uncommon Aspergillus Species Against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method

Posteraro, Brunella
Secondo
;
Vella, Antonietta;De Carolis, Elena;Torelli, Riccardo;D'Inzeo, Tiziana;Sanguinetti, Maurizio
Ultimo
2017

Abstract

We tested 59 common and 27 uncommon Aspergillus species isolates for the susceptibility to the mold-active azole antifungal agents, itraconazole, voriconazole, and posaconazole, using the Sensititre method. The overall essential agreement with the CLSI reference method was 96.5% for itraconazole and posaconazole, and 100% for voriconazole. By Sensititre, as well as CLSI, all of 10 A. fumigatus isolates with a cyp51 mutant genotype were classified as being non-wild-type (MIC > ECV) to triazoles.
2017
Inglese
Mello, E., Posteraro, B., Vella, A., De Carolis, E., Torelli, R., D'Inzeo, T., Verweij, P. E., Sanguinetti, M., Susceptibility Testing of Common and Uncommon Aspergillus Species Against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method, <<ANTIMICROBIAL AGENTS AND CHEMOTHERAPY>>, 2017; 61 (6): 00168-17-N/A. [doi:10.1128/AAC.00168-17] [http://hdl.handle.net/10807/98185]
File in questo prodotto:
File Dimensione Formato  
Antimicrobial Agents and Chemotherapy-2017-Mello-e00168-17.full.pdf

non disponibili

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 186.98 kB
Formato Unknown
186.98 kB Unknown   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/98185
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 23
social impact